Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Complications of total hip arthroplasty

INTRODUCTION

Most complications in total hip arthroplasty are infrequent and can be prevented or treated readily if anticipated and recognized. Complications associated with any major surgical procedure, including those related to anesthesia, comorbid medical conditions, medications, and allergic reactions, may also occur.

Potential complications known to occur during or following total hip arthroplasty will be reviewed here. The complications can be categorized as intraoperative or postoperative. The preoperative assessment, the alternatives to total hip arthroplasty, and an overview of the surgical procedure itself are presented separately. (See "Total hip arthroplasty".)

INTRAOPERATIVE COMPLICATIONS

Fracture — The incidence of fracture during total hip arthroplasty ranges from 0.1 to 1 percent for cemented components and from 3 to 18 percent for uncemented components [1]. Most intraoperative fractures occur on the femoral side during stem insertion. Minor fractures may be left alone or treated with wires or cables. More extensive fractures may require more complex solutions including revision of components, bone grafting, and/or supplementary hardware (eg, plates and screws). Factors that increase the risk of fracture during primary arthroplasty include female sex, osteopenia, inflammatory arthropathies, and cementless stem fixation. The use of longer-stem cementless implants during revision surgery is an additional risk factor for fracture [2].

Nerve injury — The incidence of nerve injury in primary total hip arthroplasty ranges from 0 to 3 percent [3]. Injury to the sciatic nerve is most common, but the femoral, obturator, and superior gluteal nerves may also be injured. The peroneal division of the sciatic nerve is more susceptible to injury than the tibial division.

Risk factors — Risk factors for nerve injury include previous surgery, developmental dysplasia of the hip, lengthening of the extremity, obesity, and female sex.

                                            

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Oct 2014. | This topic last updated: Mar 29, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Saleh KJ, Kassim R, Yoon P, Vorlicky LN. Complications of total hip arthroplasty. Am J Orthop (Belle Mead NJ) 2002; 31:485.
  2. Davidson D, Pike J, Garbuz D, et al. Intraoperative periprosthetic fractures during total hip arthroplasty. Evaluation and management. J Bone Joint Surg Am 2008; 90:2000.
  3. DeHart MM, Riley LH Jr. Nerve injuries in total hip arthroplasty. J Am Acad Orthop Surg 1999; 7:101.
  4. Beksaç BP, Della Valle AG, Salvati EA. Acute sciatic nerve palsy as a delayed complication of low-molecular-weight heparin prophylaxis after total hip arthroplasty. Am J Orthop (Belle Mead NJ) 2009; 38:E28.
  5. Schmalzried TP, Noordin S, Amstutz HC. Update on nerve palsy associated with total hip replacement. Clin Orthop Relat Res 1997; :188.
  6. Nachbur B, Meyer RP, Verkkala K, Zürcher R. The mechanisms of severe arterial injury in surgery of the hip joint. Clin Orthop Relat Res 1979; :122.
  7. Sharma DK, Kumar N, Mishra V, Howell FR. Vascular injuries in total hip replacement arthroplasty: a review of the problem. Am J Orthop (Belle Mead NJ) 2003; 32:487.
  8. Wasielewski RC, Cooperstein LA, Kruger MP, Rubash HE. Acetabular anatomy and the transacetabular fixation of screws in total hip arthroplasty. J Bone Joint Surg Am 1990; 72:501.
  9. Patterson BM, Healey JH, Cornell CN, Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am 1991; 73:271.
  10. Paiement GD. Prevention and treatment of venous thromboembolic disease complications in primary hip arthroplasty patients. Instr Course Lect 1998; 47:331.
  11. Burnett RS, Clohisy JC, Wright RW, et al. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty 2007; 22:317.
  12. Januel JM, Chen G, Ruffieux C, et al. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA 2012; 307:294.
  13. Pellicci PM, Bostrom M, Poss R. Posterior approach to total hip replacement using enhanced posterior soft tissue repair. Clin Orthop Relat Res 1998; :224.
  14. White RE Jr, Forness TJ, Allman JK, Junick DW. Effect of posterior capsular repair on early dislocation in primary total hip replacement. Clin Orthop Relat Res 2001; :163.
  15. Demos HA, Rorabeck CH, Bourne RB, et al. Instability in primary total hip arthroplasty with the direct lateral approach. Clin Orthop Relat Res 2001; :168.
  16. Morrey BF. Difficult complications after hip joint replacement. Dislocation. Clin Orthop Relat Res 1997; :179.
  17. Dewal H, Maurer SL, Tsai P, et al. Efficacy of abduction bracing in the management of total hip arthroplasty dislocation. J Arthroplasty 2004; 19:733.
  18. Shah SN, Kaye RJ, Kelly NH, et al. Retrieval analysis of failed constrained acetabular liners. J Arthroplasty 2009; 24:54.
  19. Kobayashi A, Freeman MA, Bonfield W, et al. Number of polyethylene particles and osteolysis in total joint replacements. A quantitative study using a tissue-digestion method. J Bone Joint Surg Br 1997; 79:844.
  20. Drees P, Eckardt A, Gay RE, et al. Mechanisms of disease: Molecular insights into aseptic loosening of orthopedic implants. Nat Clin Pract Rheumatol 2007; 3:165.
  21. Mandelin J, Li TF, Hukkanen MV, et al. Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses. J Rheumatol 2003; 30:2033.
  22. Ma GF, Liljeström M, Ainola M, et al. Expression of ADAM9 (meltrin-gamma) around aseptically loosened total hip replacement implants. Rheumatology (Oxford) 2006; 45:808.
  23. Ma G, Ainola M, Liljeström M, et al. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants. J Rheumatol 2005; 32:1943.
  24. Mandelin J, Li TF, Hukkanen M, et al. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. J Rheumatol 2005; 32:713.
  25. Walde TA, Weiland DE, Leung SB, et al. Comparison of CT, MRI, and radiographs in assessing pelvic osteolysis: a cadaveric study. Clin Orthop Relat Res 2005; :138.
  26. McCalden RW, MacDonald SJ, Rorabeck CH, et al. Wear rate of highly cross-linked polyethylene in total hip arthroplasty. A randomized controlled trial. J Bone Joint Surg Am 2009; 91:773.
  27. Callaghan JJ, Cuckler JM, Huddleston JI, et al. How have alternative bearings (such as metal-on-metal, highly cross-linked polyethylene, and ceramic-on-ceramic) affected the prevention and treatment of osteolysis? J Am Acad Orthop Surg 2008; 16 Suppl 1:S33.
  28. Shanbhag AS, Hasselman CT, Rubash HE. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 1997; :33.
  29. Arabmotlagh M, Pilz M, Warzecha J, Rauschmann M. Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty. J Orthop Res 2009; 27:183.
  30. Prieto-Alhambra D, Javaid MK, Judge A, et al. Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 2011; 343:d7222.
  31. American Academy of Orthopaedic Surgeons. Modern metal-on-metal hip implants: A technology overview. December 2, 2011. http://www.aaos.org/research/overviews/Metal_On_Metal.pdf (Accessed on March 29, 2013).
  32. Griffin WL, Nanson CJ, Springer BD, et al. Reduced articular surface of one-piece cups: a cause of runaway wear and early failure. Clin Orthop Relat Res 2010; 468:2328.
  33. Langton DJ, Jameson SS, Joyce TJ, et al. Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: A consequence of excess wear. J Bone Joint Surg Br 2010; 92:38.
  34. Browne JA, Bechtold CD, Berry DJ, et al. Failed metal-on-metal hip arthroplasties: a spectrum of clinical presentations and operative findings. Clin Orthop Relat Res 2010; 468:2313.
  35. FDA Medical Devices: Metal-on-Metal Implants. http://www.fda.gov/medicaldevices/productsandmedicalprocedures/implantsandprosthetics/metalonmetalhipimplants/default.htm (Accessed on March 12, 2013).
  36. FDA Safety Communication: Metal-on-Metal Hip Implants. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm335775.htm (Accessed on March 12, 2013).
  37. MHRA Medical Device Alert MDA/2012/036 All metal-on-metal (MoM) hip replacements. http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON155761 (Accessed on March 12, 2013).
  38. Terefenko KM, Sychterz CJ, Orishimo K, Engh CA Sr. Polyethylene liner exchange for excessive wear and osteolysis. J Arthroplasty 2002; 17:798.
  39. Rubash HE, Sinha RK, Paprosky W, et al. A new classification system for the management of acetabular osteolysis after total hip arthroplasty. Instr Course Lect 1999; 48:37.
  40. Maloney WJ, Herzwurm P, Paprosky W, et al. Treatment of pelvic osteolysis associated with a stable acetabular component inserted without cement as part of a total hip replacement. J Bone Joint Surg Am 1997; 79:1628.
  41. Katz JN, Wright EA, Wright J, et al. Twelve-year risk of revision after primary total hip replacement in the U.S. Medicare population. J Bone Joint Surg Am 2012; 94:1825.
  42. Duncan CP, Masri BA. Fractures of the femur after hip replacement. Instr Course Lect 1995; 44:293.
  43. Greidanus NV, Mitchell PA, Masri BA, et al. Principles of management and results of treating the fractured femur during and after total hip arthroplasty. Instr Course Lect 2003; 52:309.
  44. Heck DA, Partridge CM, Reuben JD, et al. Prosthetic component failures in hip arthroplasty surgery. J Arthroplasty 1995; 10:575.
  45. Galante JO. Causes of fractures of the femoral component in total hip replacement. J Bone Joint Surg Am 1980; 62:670.
  46. Jazrawi LM, Della Valle CJ, Kummer FJ, et al. Catastrophic failure of a cemented, collarless, polished, tapered cobalt-chromium femoral stem used with impaction bone-grafting. A report of two cases. J Bone Joint Surg Am 1999; 81:844.
  47. Chao EY, Coventry MB. Fracture of the femoral component after total hip replacement. An analysis of fifty-eight cases. J Bone Joint Surg Am 1981; 63:1078.
  48. Butler DR. A Minute With Malpractice. The American Academy of Orthopaedic Surgeons Bulletin; July 1995; 43:3.
  49. Abraham WD, Dimon JH 3rd. Leg length discrepancy in total hip arthroplasty. Orthop Clin North Am 1992; 23:201.
  50. DeLee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop Relat Res 1976; :53.
  51. Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am 1977; 59:345.
  52. Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment. J Am Acad Orthop Surg 2002; 10:409.
  53. Ahrengart L, Lindgren U. Heterotopic bone after hip arthroplasty. Defining the patient at risk. Clin Orthop Relat Res 1993; :153.
  54. Horwitz BR, Rockowitz NL, Goll SR, et al. A prospective randomized comparison of two surgical approaches to total hip arthroplasty. Clin Orthop Relat Res 1993; :154.
  55. Maloney WJ, Krushell RJ, Jasty M, Harris WH. Incidence of heterotopic ossification after total hip replacement: effect of the type of fixation of the femoral component. J Bone Joint Surg Am 1991; 73:191.
  56. Nayak KN, Mulliken B, Rorabeck CH, et al. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial. Can J Surg 1997; 40:368.
  57. Purtill JJ, Eng K, Rothman RH, Hozack WJ. Heterotopic ossification. Incidence in cemented versus cementless total hip arthroplasty. J Arthroplasty 1996; 11:58.
  58. Wixson RL, Stulberg SD, Mehlhoff M. Total hip replacement with cemented, uncemented, and hybrid prostheses. A comparison of clinical and radiographic results at two to four years. J Bone Joint Surg Am 1991; 73:257.
  59. Kjaersgaard-Andersen P, Schmidt SA, Pedersen NW, et al. Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty. Clin Orthop Relat Res 1989; :189.
  60. Kjaersgaard-Andersen P, Pedersen P, Kristensen SS, et al. Serum alkaline phosphatase as an indicator of heterotopic bone formation following total hip arthroplasty. Clin Orthop Relat Res 1988; :102.
  61. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973; 55:1629.
  62. Birrell F, Lohmander S. Non-steroidal anti-inflammatory drugs after hip replacement. BMJ 2006; 333:507.
  63. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004; :CD001160.
  64. Barthel T, Baumann B, Nöth U, Eulert J. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand 2002; 73:611.
  65. Saudan M, Saudan P, Perneger T, et al. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Joint Surg Br 2007; 89:155.
  66. Romanò CL, Duci D, Romanò D, et al. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 2004; 19:14.
  67. Amstutz HC, Fowble VA, Schmalzried TP, Dorey FJ. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty. J Arthroplasty 1997; 12:126.
  68. Fransen M, Anderson C, Douglas J, et al. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 2006; 333:519.
  69. Pakos EE, Ioannidis JP. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys 2004; 60:888.
  70. Healy WL, Lo TC, DeSimone AA, et al. Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. A comparison of doses of five hundred and fifty and seven hundred centigray. J Bone Joint Surg Am 1995; 77:590.
  71. Gregoritch SJ, Chadha M, Pelligrini VD, et al. Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results. Int J Radiat Oncol Biol Phys 1994; 30:55.
  72. Lonardi F, Gioga G, Coeli M, et al. Preoperative, single-fraction irradiation for prophylaxis of heterotopic ossification after total hip arthroplasty. Int Orthop 2001; 25:371.
  73. Seegenschmiedt MH, Makoski HB, Micke O, German Cooperative Group on Radiotherapy for Benign Diseases. Radiation prophylaxis for heterotopic ossification about the hip joint--a multicenter study. Int J Radiat Oncol Biol Phys 2001; 51:756.
  74. Balboni TA, Gaccione P, Gobezie R, Mamon HJ. Shielding of the hip prosthesis during radiation therapy for heterotopic ossification is associated with increased failure of prophylaxis. Int J Radiat Oncol Biol Phys 2007; 67:1499.